Secukinumab biosimilar (Gan & Lee)
司库奇尤单抗生物类似药（甘李药业）
Report date: 2023/07/20 10:20:35
Base Information
Drug NameSecukinumab biosimilar (Gan & Lee)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGan & Lee Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesGan & Lee Pharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A